Imaging Advantage icotec's BlackArmor Carbon/PEEK spinal implants enable artifact-free CT and MRI imaging, helping radiation oncology teams delineate critical structures accurately and plan doses more quickly while maintaining radiolucency during radiotherapy and enabling quicker detection of recurrences on follow-up imaging.

Growth Momentum Recent recognition with a SEF.Growth high potential label in 2025, exclusive UK distribution with Osteotec, and 2024 growth financing alongside US leadership changes signal expansion momentum and opportunities for channel partners and joint marketing.

Market Position As a world leader in non-metallic spinal implants for spine cancer treatment, icotec offers a compelling value proposition to hospitals and oncology centers, with ongoing development such as a new generation pedicle system through AO collaboration.

Quality Edge ISO 13485 certification and Swiss origin underpin regulatory readiness and quality management, making icotec an attractive partner for health systems that require compliant implant solutions and robust post market support.

Pipeline Opportunity A promising product pipeline including a new generation pedicle system suggests cross sell opportunities with spine instrumentation and potential bundles with imaging or radiotherapy planning services to accelerate adoption across markets.